Skip to main content
editor@jprims.in
9343055451
e-ISSN: 3049-1681
Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical
Research and Integrated Medical Sciences

Advancing knowledge through rigorous peer-reviewed research across multiple disciplines. Join the global community of scholars shaping the future of academic discovery.

📢 Latest Update: New special issue call for papers on "Pharmaceutical Research and Integrated Medical Sciences" - Submit by September 30, 2026

📢 Latest Update: New special issue call for papers on "Pharmaceutical Research and Integrated Medical Sciences" - Submit by September 30, 2026

Important Journal Details

Title:
Journal of Pharmaceutical Research and Integrated Medical Sciences
Journal Short Name:
JPRIMS
e-ISSN (Online):
3049-1681
Year of Establishment (Online):
2024
Frequency of the Publication:
Monthly (1 Issue / month)
Publication Format:
Online
Scope:
International
Publication URL:
https://jprims.in
Related Subject:
Multi-DisciplinaryMedical Sciences
Language:
English
Editor-in-Chief:
Dr. Arpan Kumar Tripathi
Editorial Board:
Click Here →
Journal's Email ID:
editor@jprims.in

Download Forms & Formats

Download Hub

Publisher Details

Responsible Person Name:
Dr. Arpan Kumar Tripathi
Name of Publishing body:
AKT Publication
Publisher Website Url:
https://www.aktpublication.com
Address:
H-103, Nandi Parishar, Padmanabhpur, Durg, Chhattisgarh-491001

Journal Features

Rigorous Peer Review

All submissions undergo thorough evaluation by experts in the field to ensure quality and validity.

Global Reach

Published papers reach an international audience of researchers, academics, and industry professionals.

Rapid Publication

Efficient review process ensures timely publication of accepted papers without compromising quality.

Open Access

All published papers are freely accessible online, maximizing visibility and impact of your research.

Publication Procedure

1

Prepare Manuscript

Format your paper according to our guidelines

View Guidelines
style="fill: var(--journal-600);"
2

Submit Paper

Upload your manuscript through our system

Submit Now
3

Peer Review

Your paper undergoes expert evaluation

Learn More
4

Publication

Accepted papers are published worldwide

View Publications
View All Issues
Cover image for Hypoglycemic Effect of Methanolic Extract of Annona Squmosa L. (Seeds) on Streptozotocin-Induced Diabetes in Rats

Hypoglycemic Effect of Methanolic Extract of Annona Squmosa L. (Seeds) on Streptozotocin-Induced Diabetes in Rats

Bhulaxmi, Arpan Kumar Tripathi

The purity, safety, and long-term therapeutic efficacy of Annona squamosa L. seed extract in the treatment of diabetes were thoroughly assessed. Petroleum ether defatting and Soxhlet methanolic extraction came with the establishment of physicochemical standards (ash values). High levels of total phenolic content (TPC) and total flavonoid content (TFC), which provided notable in vitro antioxidant and anti-glycation properties, were shown by quantitative phytochemical screening. According to OECD Guideline 420 (Fixed Dose Procedure), acute oral toxicity testing verified that the extract has a broad margin of safety, showing no evidence of acute toxicity or fatality up to the highest suggested limit dose. Oral administration of Annona squamosa L. seed extract (200 mg/kg and 400 mg/kg) significantly decreased fasting blood glucose levels and reversed progressive body weight loss in an 8-week in vivo study on streptozotocin (STZ, 50–55 mg/kg)-induced diabetic Wistar rats when compared to untreated diabetic controls. The therapeutic efficacy of the 400 mg/kg dose was similar to that of normal Glibenclamide (10 mg/kg). To sum up, Annona squamosa L. seed methanolic extract is a safe, flavonoid-rich, antioxidant-rich substance that successfully reduces glycation, hyperglycemia, and weight loss in people with chronic diabetes.

Cover image for Ethanolic Leaf Extract of Chenopodium album Linn. Attenuates Calcium Oxalate-Associated Urolithiasis in Rats: An Integrated In Vitro and In Vivo Evaluation

Ethanolic Leaf Extract of Chenopodium album Linn. Attenuates Calcium Oxalate-Associated Urolithiasis in Rats: An Integrated In Vitro and In Vivo Evaluation

Arpan Kumar Tripathi, Yashika, Deleshwar Kumar

Background: The primary stone component in urolithiasis, a recurrent urinary tract disease characterized by crystal nucleation, development, aggregation, and retention, is calcium oxalate (CaOx). Chenopodium album Linn. has a long history of ethnomedical use for urinary and renal issues and has demonstrated an initial anti-crystallization effect. However, little information is known about the relationship between in vivo renal and urinary outcomes and in vitro CaOx crystallization. Objective: This study evaluated the anti-urolithiatic potential of an ethanolic leaf extract of C. album (EECA) using complementary in vitro and in vivo techniques. Methods: The leaves were subjected to Soxhlet extraction using ethanol to obtain a 6.0% w/w extract, and preliminary phytochemical screening was carried out. The nucleation of CaOx was measured at 10–100 mg/mL, and the inhibition of crystal growth was also examined. The standard treatment was cystone (750 mg/kg). EECA was given at doses of 50 and 200 mg/kg to rats with urolithiasis associated with calcium oxalate. Urinary uric acid, urine volume, and renal histology were determined. Results: EECA inhibited CaOx nucleation in a concentration-dependent manner by 18.75% at 10 mg/mL and 77.50% at 100 mg/mL. Inhibition at 100 mg/mL exceeded the observed Cystone response of 72.50%. EECA also raised urine production and reduced urinary uric acid, particularly at 200 mg/kg. The results of the histopathology showed improved kidney structure. Conclusion: EECA demonstrated anti-crystallization and protective qualities in experimental urolithiasis, encouraging further mechanistic, phytochemical-standardizing, and translational research.

Publication Procedure

Learn about our 4-step publication process

Author Guidelines

Review requirements before submitting

Submit Article

Ready to submit your research?

167
Published Articles
1,523
Active Researchers
195
Countries
4.2
Impact Factor